Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. (Q46871186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

microvasculature remodeling

4 March 2020

main subject

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Lasse D Jensen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Kayoko Hosaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yunlong Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Takahiro Seki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Masaki Nakamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Patrik Andersson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Pegah Rouhi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xiaojuan Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sharon Lim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ninghan Feng

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yuan Xue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xuri Li

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Toshio Ohhashi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yihai Cao

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

2129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23831851%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ncomms3129

4 March 2020

exact match

0 references

cites work

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

PDGF receptors as cancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Immunological consequences of macrophage-mediated clearance of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Molecular mechanisms and therapeutic development of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Erythropoietin in cancer: a dilemma in risk therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Tumor angiogenesis and molecular targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

The extracellular matrix: not just pretty fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Integrin connections map: to infinity and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Hypoxia-Independent Angiogenesis in Adipose Tissues during Cold Acclimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

In vivo angiogenesis and lymphangiogenesis models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Improved precision and accuracy for microarrays using updated probe set definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

A random variance model for detection of differential gene expression in small microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

Cold-induced activation of brown adipose tissue and adipose angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129

inferred from DOI database lookup

7 January 2021

based on heuristic

Mouse corneal lymphangiogenesis model

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS3129